AI is all set to transform multiple processes in the Pharma industry. Research is already being done for opportunities like patient identification, site selection and clinical trials amongst others. Saama’s Chief Strategy Officer Sagar Anisingaraju writes about AI’s impact on the planning and conduct of clinical trials. He highlights the need to replicate the world famous Moore’s Law in Pharma, and how a collaborative effort of all the entities involved can actually make it happen.
Discover more insights here.